Sunflower Pharmaceutical Group

Name

Sunflower Pharmaceutical Group

Legal name

葵花药业集团股份有限公司

Website

https://kuihuayaoye.com

Company type

Public

Founded year

1998

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Sunflower Pharmaceutical Group is a Shenzhen-listed Chinese OTC pharmaceutical company that develops, manufactures, and sells branded adult medicines, premium pediatric medications, and consumer wellness products across China via integrated R&D, manufacturing, and a self-built nationwide distribution network of 30+ subsidiaries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industries

Cold, Flu & Cough Remedies (HLAIADAB), OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• OTC pharmaceuticals
• Children's medications
• Adult medicines
• Health supplements
• Pharmaceutical manufacturing

Headquarters

HQ city

Harbin

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. OTC Pharmaceutical Sales: Primary revenue stream from branded Over-The-Counter (OTC) pharmaceutical products sold through multiple distribution channels including online e-commerce platforms and offline pharmaceutical retail networks across China.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Sunflower Pharmaceutical Group manufactures and sells branded Over-The-Counter (OTC) pharmaceutical products across three segments: adult medicines (covering cold/flu, gynecology, rheumatism/bone disease, cardiovascular/cerebrovascular, hepatobiliary/gastrointestinal, and tonics), premium pediatric medications, and big-health/wellness products. The group operates a fully integrated value chain spanning R&D, manufacturing, and sales through 12 manufacturing enterprises, 6 sales companies, 4 research institutes, and 2 medicinal herb planting bases, distributing to Chinese consumers via flagship stores on Tmall, JD.com, WeChat, Douyin, Weibo, and a self-built nationwide offline retail network.

Differentiator

Problem solved

Functional benefit

Products and services

• Wei Kang Ling Capsules (胃康灵胶囊) Capsule medication for digestive system disorders, featured as a core adult medicine product in Sunflower's product center. Targeted at adult Chinese consumers seeking OTC treatment for gastrointestinal conditions.
• Mesalazine Enteric-coated Tablets (美沙拉嗪肠溶片) Enteric-coated tablets for inflammatory bowel conditions, featured as a core adult medicine product. Targeted at adult patients managing inflammatory bowel disease via OTC channels.
• Kangfu Xiaoyan Suppository (康妇消炎栓) Gynecological anti-inflammatory suppository product positioned in Sunflower's gynecology series for women's health. Targeted at adult female consumers seeking OTC anti-inflammatory treatment.
• Hugan Tablets (护肝片) Liver protection tablets for hepatobiliary health positioned in Sunflower's hepatobiliary/gastrointestinal series. Targeted at adult consumers seeking OTC liver care.
• Flurbiprofen Gel Patches (氟比洛芬凝胶贴膏) Topical gel patch medication based on flurbiprofen, intended for pain/inflammation management. Drug registration certificate received by Longzhong Sunflower (a Sunflower subsidiary) in 2024.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Broad incumbents

• Livzon Pharmaceutical Group: Diversified Chinese pharmaceutical manufacturer with branded OTC and consumer health products that overlap with Sunflower's gastrointestinal, gynecological, and tonic product lines.
• China Resources Double-Crane Pharmaceutical: Large Chinese pharmaceutical manufacturer with branded OTC and consumer health offerings targeting overlapping consumer segments, providing a comparable state-owned incumbent benchmark.
• Guangzhou Baiyunshan Pharmaceutical Holdings: Large state-owned Chinese pharmaceutical conglomerate with a broad OTC and consumer health portfolio serving the same end customers; broader than Sunflower but overlapping in several therapeutic categories.
• Shanghai Pharmaceuticals Holding: Diversified Chinese pharmaceutical group with both manufacturing and distribution operations that overlaps with Sunflower's vertically integrated model across branded pharmaceutical and OTC products.

Direct peers

• Zhangzhou Pien Tze Huang Pharmaceutical: Chinese specialty pharmaceutical and OTC brand with a similar emphasis on proprietary traditional formulations and brand equity, competing in overlapping Chinese consumer health and OTC categories.
• Tianjin Zhongxin Pharmaceutical Group: Chinese traditional medicine and OTC pharmaceutical company with branded consumer health products distributed through similar pharmacy and retail channels across China.
• Yunnan Baiyao Group: Major Chinese OTC and traditional medicine brand with similar multi-category portfolio, brand-led GTM, and nationwide pharmacy distribution, making it one of the most direct comparable peers in the Chinese OTC space.
• Beijing Tongrentang: Iconic Chinese traditional medicine and OTC pharmaceutical brand with a comparable self-built nationwide retail and distribution network and brand-driven go-to-market strategy overlapping with Sunflower's positioning.
• China Resources Sanjiu Medical & Pharmaceutical: Leading Chinese OTC pharmaceutical company with a comparable self-built brand and distribution model across cold, pediatric, and consumer health categories, directly competing with Sunflower in the same Chinese OTC market.

Emerging players

• Jiangsu Yangshengtang Pharmaceutical: Chinese health and wellness-focused pharmaceutical company competing in the big health and OTC segments where Sunflower's 大健康 category is positioned.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sunflower Pharmaceutical Group